ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
67.125,53
0,07%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Frazier LifeSciences Acquisition Corporation (FLAC)

  7. Frazier LifeSciences Acquisition Corporation (FLAC) News

FLAC

Frazier LifeSciences Acq... (FLAC)

Frazier LifeSciences Acquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FLAC
DatumZeitQuelleÜberschriftSymbolFirma
15/02/202316h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
02/12/202222h32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
01/12/202222h52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
25/11/202219h44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202222h37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202222h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202222h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202222h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202222h27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202214h00GlobeNewswire Inc.NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular DiseaseNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
22/11/202222h17Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
22/11/202222h16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
15/11/202217h31Business WireFrazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
15/11/202200h13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
09/11/202222h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
04/11/202223h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
13/10/202223h02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
05/10/202222h17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
04/10/202222h17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
28/09/202223h31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
26/09/202214h00GlobeNewswire Inc.Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of DirectorsNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/09/202222h17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
20/09/202222h31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
20/09/202212h07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
29/08/202222h16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
24/08/202223h04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
19/08/202223h01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
17/08/202222h32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
16/08/202223h07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/08/202223h28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:FLAC

Kürzlich von Ihnen besucht

GDAX
PONDUSDT
Marlin
EU
INSRI
BNPP MUSRI INAV
BIT
P22BT5
NLBNPIT22BT5 20351221 13...
BIT
S30569
Societe Generale Effekten
BIT
P1ZO05
NLBNPIT1ZO05 20241220 32
COIN
ARBITUSD
ASX
XJOLOT
LSE
12XV
Rep Chile 27
BIT
S31340
Societe Generale Effekten
LSE
BDVA
Baronsmead Vct
BIT
P1ZCQ0
NLBNPIT1ZCQ0 20240920 600
COIN
HUREUR
BIT
P1X5A3
NLBNPIT1X5A3 20240920 35
AQSE
VUAG.GB
Vanguard Funds
BIT
P1WDV5
NLBNPIT1WDV5 20240621 5.2
BIT
P21GS8
NLBNPIT21GS8 20991231 20...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten